TTK and colorectal carcinoma: Employing multiple approaches and through integration with patients’ derived transcriptomic data, we identified numerous actionable gene targets based on the TPX2/TTK network, and suggested their potential use in the clinical management of CRC, which warrants further investigations under preclinical and clinical settings.